Glial senescence in Alzheimer’s disease
Does senescence in the brain’s support cells help drive cognitive decline in Alzheimer’s disease?
It could clarify how aging, glial senescence, inflammation, and tau-related pathology connect to cognitive decline. Evidence over time could distinguish a contributor to disease from a process that accompanies it.
Where it stands now
Main bottleneck
Current evidence does not establish whether glial senescence causally drives cognitive decline or whether changing it improves outcomes.
Watch next
Controlled evidence showing whether selectively changing glial senescence alters cognitive outcomes, alongside measurements of brain inflammation and tau-related pathology.
Progress timeline
How the evidence has changed over time.
2023 · 2 updates
- Could aging brain support cells help turn pathology into memory loss?Research note 1 of 2 · Source date 2023-03-25
- How tau aggregates and altered brain support cells create different Alzheimer's targetsResearch note 2 of 2 · Source date 2023-10-09
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: Could aging brain support cells help turn pathology into memory loss?
Previous expectation: Selectively removing or disabling harmful senescent glia might eventually help preserve memory alongside treatments for other Alzheimer's pathology.
What this study adds: The October 2023 review organizes evidence around different tau forms, senescent cell types and inflammatory secretions, widening the comparison beyond glial clearance to secretion suppression and tau-directed approaches. It also highlights drug effects that may occur independently of senescent-cell removal.
Current research note
How this Track works
This page changes as new evidence arrives. Open any update to see what researchers found at that point in the story.